Summary
The paper discusses the development and testing of artificial retinal implants, which are used to partially restore sight in blind patients suffering from retinal degeneration.
Categories
Eye health: The paper discusses the development and testing of artificial retinal implants, which are used to partially restore sight in blind patients suffering from retinal degeneration.
Education and learning: The paper is a result of a research internship and discusses the learning and research process involved in developing the retinal implants.
Aging: The paper mentions that diseases like Age-related Macular Degeneration are increasingly present in aging societies like France, leading to a need for treatments like the retinal implants discussed.
Author(s)
T Andréoletti, B Cessac, F Chavane
Publication Year
2018
Related Publications
Eye health
- Phototransduction by retinal ganglion cells that set the circadian clock
- Color appearance models
- Diminished pupillary light reflex at high irradiances in melanopsin-knockout mice
- Strange vision: ganglion cells as circadian photoreceptors
- Genetic reactivation of cone photoreceptors restores visual responses in retinitis pigmentosa
Education and learning
- Color appearance models
- Genetic dissection of retinal inputs to brainstem nuclei controlling image stabilization
- The role of the circadian system in the etiology and pathophysiology of ADHD: time to redefine ADHD?
- How to report light exposure in human chronobiology and sleep research experiments
- Simulation-aided occupant-centric building design: A critical review of tools, methods, and applications
Aging
- Light therapy and Alzheimer's disease and related dementia: past, present, and future
- Function of human pluripotent stem cell-derived photoreceptor progenitors in blind mice
- Melanopsin-expressing intrinsically photosensitive retinal ganglion cells in retinal disease
- Neuroprotective strategies for retinal ganglion cell degeneration: current status and challenges ahead
- Combinatorial effects of alpha-and gamma-protocadherins on neuronal survival and dendritic self-avoidance